Feasibility and Outcomes of Hypofractionated Simultaneous ...

An escalated dose of hypofractionated SIB-IMRT using three-layered PTVs can be safely performed in patients with malignant glioma, and might contribute to ...

Feasibility and outcomes of hypofractionated simultaneous ...

An escalated dose of hypofractionated SIB-IMRT using three-layered PTVs can be safely performed in patients with malignant glioma, and might contribute to ...

Safety and Feasibility of Simultaneous Integrated Boost in Extreme 1 ...

The phase 3 FAST-Forward trial reported that 26 Gy in 5 fractions (fx) over 1 week for early-breast cancer patients after breast conserving surgery was ...

Accelerated hypofractionated breast radiotherapy with simultaneous ...

To assess the feasibility of accelerated hypofractionated radiotherapy with simultaneous integrated boost (SIB) in patients with breast cancer.

Safety and Feasibility of Simultaneous Integrated Boost in Extreme 1 ...

The phase 3 FAST-Forward trial reported that 26 Gy in 5 fractions (fx) over 1 week for early-breast cancer patients after breast conserving surgery was ...

A Report of Feasibility and Acute Toxicity Results in the First 50 ...

Phase I-II Study of Hypofractionated Simultaneous Integrated Boost (SIB) for Adjuvant Radiation Therapy in Early Breast Cancer Patients: A Report of Feasibility ...

Phase I-II study of hypofractionated simultaneous integrated boost ...

To report results in terms of feasibility and early toxicity of hypofractionated simultaneous integrated boost (SIB) approach with ...

Long-term oncological outcomes of hypofractionated versus ...

For patients with early breast cancer who undergo breast-conserving surgery, adjuvant whole breast irradiation (WBI) with simultaneous ...

Feasibility and effects of high-dose hypofractionated radiation ...

The combination of RT with simultaneous systemic treatment using sunitinib is effective in patients with progressive mRCC. With high dose RT, complete response ...

[PDF] Accelerated hypofractionated breast radiotherapy with ...

Purpose To assess the feasibility of accelerated hypofractionated radiotherapy with simultaneous integrated boost (SIB) in patients with breast cancer ...

Adjuvant hypofractionated radiotherapy with simultaneous ...

Our results show that hypofractionated whole-breast radiotherapy with SIB is safe and feasible with low rates of acute toxicity. The SIB has ...

429P Feasibility and toxicity of hypofractionated radiotherapy (5x5 ...

Hypofractionated RT (5x5 Gy) with or without subsequent chemotherapy (CTx) is a standard of care used at National Institute of Oncology, Warsaw, ...

Feasibility of a simultaneously integrated boost concept for ...

Two plans were generated, one according to the classical 80% concept with 5 times 7 Gy prescribed (on D2%) to the 80% PTV surrounding isodose ( ...

Phase I-II study of hypofractionated simultaneous integrated boost ...

Background To report results in terms of feasibility and early toxicity of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric ...

Accelerated hypofractionated breast radiotherapy with simultaneous ...

Purpose: To assess the feasibility of accelerated hypofractionated radiotherapy with simultaneous integrated boost (SIB) in patients with breast cancer.

Long term results of two phase-II trials - The Breast

Hypofractionated breast radiotherapy with SIB was safe and feasible. ... Intensity-modulated and hypofractionated simultaneous integrated ...

Accelerated hypofractionated breast radiotherapy with simultaneous ...

Document Type: Article ; Subject Terms: *ACCELERATED partial breast irradiation *VOLUMETRIC-modulated arc therapy *LUMPECTOMY *BRACHIAL plexus *FEASIBILITY ...

Feasibility and Outcomes of Hypofractionated Simultaneous ...

Total dose to high risk PTV was 70 Gy in 8 and 62.5 Gy in 4 patients.ResultsThe median follow-up time was 52 months in surviving patients. The 2 ...

Accelerated hypofractionated adjuvant whole breast radiation with ...

Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: ...

Phase I-II study of hypofractionated simultaneous integrated boost ...

... feasibility and early toxicity results in the first 50 treatments. https://doi.org/10.1186/1748-717x-7-145 · Full text. Journal: Radiation Oncology, 2012, № 1.